The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127121092 12712109 2 F 20160721 20160906 20160902 20160920 EXP FR-PFIZER INC-2016403605 PFIZER 65.00 YR F Y 0.00000 20160920 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127121092 12712109 1 PS Carboplatine Hospira CARBOPLATIN 1 Intravenous (not otherwise specified) 300 MG, SINGLE Y 77059 300 MG SOLUTION FOR INJECTION
127121092 12712109 2 SS IFOSFAMIDE EG IFOSFAMIDE 1 Intravenous (not otherwise specified) 6 G, SINGLE Y 0 6 G SOLUTION FOR INFUSION
127121092 12712109 3 SS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) 600 MG, SINGLE Y 0 600 MG
127121092 12712109 4 SS OXYCODONE MYLAN LP OXYCODONE 1 Oral 40 MG, 1X/DAY Y 0 40 MG PROLONGED-RELEASE TABLET QD
127121092 12712109 5 SS EMEND APREPITANT 1 Oral UNK Y 0
127121092 12712109 6 C DEXAMETHASONE. DEXAMETHASONE 1 UNK 0
127121092 12712109 7 C DIAMICRON GLICLAZIDE 1 UNK 0
127121092 12712109 8 C GRANOCYTE LENOGRASTIM 1 UNK 0
127121092 12712109 9 C KARDEGIC ASPIRIN LYSINE 1 UNK 0
127121092 12712109 10 C LASILIX /00032601/ FUROSEMIDE 1 UNK 0
127121092 12712109 11 C LEVEMIR INSULIN DETEMIR 1 UNK 0
127121092 12712109 12 C LEVOTHYROX LEVOTHYROXINE 1 UNK 0
127121092 12712109 13 C METFORMIN METFORMIN HYDROCHLORIDE 1 UNK 0
127121092 12712109 14 C OROZAMUDOL TRAMADOL 1 UNK 0
127121092 12712109 15 C PRAVASTATIN SODIUM. PRAVASTATIN SODIUM 1 UNK 0
127121092 12712109 16 C PRIMPERAN METOCLOPRAMIDE HYDROCHLORIDE 1 UNK 0
127121092 12712109 17 C RAMIPRIL. RAMIPRIL 1 UNK 0
127121092 12712109 18 C SOTALOL HYDROCHLORIDE. SOTALOL HYDROCHLORIDE 1 UNK 0
127121092 12712109 19 C TARDYFERON FERROUS SULFATE 1 UNK 0
127121092 12712109 20 C ZELITREX VALACYCLOVIR HYDROCHLORIDE 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127121092 12712109 1 B-cell lymphoma stage IV
127121092 12712109 2 B-cell lymphoma stage IV
127121092 12712109 3 B-cell lymphoma stage IV
127121092 12712109 4 Analgesic therapy
127121092 12712109 5 Prophylaxis of nausea and vomiting

Outcome of event

Event ID CASEID OUTC COD
127121092 12712109 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127121092 12712109 Encephalopathy

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127121092 12712109 1 20160720 20160720 0
127121092 12712109 2 20160721 20160721 0
127121092 12712109 3 20160719 20160719 0
127121092 12712109 4 20160721 20160722 0
127121092 12712109 5 20160719 20160721 0